Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Neoadjuvant docetaxel, oxaliplatin and S-1 therapy for the patients with large type 3 or type 4 gastric cancer (OGSG1902): protocol of a multi-center, phase II study

Fig. 1

The participant flow diagram. PS Eastern Cooperative Oncology Group Performance Status. Clinicopathological findings of gastric cancer are written according the Japanese Classification of Gastric Carcinoma (15th edition) and the surgical procedures are written according to the Japanese Gastric Cancer Treatment Guidelines 2018 (5th edition)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us